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Abstract
Introduction: Current guidelines recommend maintaining central venous oxygen saturation (ScvO2) higher than
70% in patients with severe sepsis and septic shock. As high levels of ScvO2 may reflect an inadequate use of
oxygen, our aim was to evaluate the relation between maximal ScvO2 levels (ScvO2max) and survival among
intensive care unit (ICU) patients with septic shock.
Methods: We retrospectively analyzed data from all admissions to our ICU between January 2008 and December
2009. All septic shock patients in whom the ScvO2 was measured were included. The measures of ScvO2max within
the first 72 hours after the onset of shock were collected.
Results: A total of 1,976 patients were screened and 152 (7.7%) patients met the inclusion criteria. The level of
ScvO2max was 85% (78 to 89) in the non-survivors, compared with 79% (72 to 87) in the survivors (P = 0.009).
Conclusions: Our findings raise concerns about high levels of ScvO2 in patients with septic shock. This may reflect
the severity of the shock with an impaired oxygen use. Future strategies may target an optimization of tissue
perfusion in this specific subgroup of patients.
Introduction
Shock is characterized by either an inadequacy between
tissue requirements in oxygen and oxygen delivery or the
inadequate use of oxygen. The hemodynamic management
of patients in shock aims at improving tissue oxygenation.
Central venous blood saturation in oxygen (ScvO2)i sa
useful tool reflecting the global transport and metabolism
of oxygen. International guidelines suggest the need to
optimize ScvO2 in the early phase of management of
severe sepsis and septic shock [1].
Low levels reflect (i) an inadequate cardiac output with
an excessive extraction of oxygen [2], (ii) a low hemoglo-
bin concentration, and/or (iii) a low level of arterial oxygen
pressure (PaO2). In contrast, high levels of ScvO2 means
either (i) a very high oxygen delivery in excess of tissue
requirements and/or (ii) decreased cellular consumption
of oxygen (mitochondrial dysfunction) and/or (iii) more
rarely, a large arterio-venous shunt. In its most simple
form, the oxyhemoglobin dissociation curve describes the
relation between the partial pressure of oxygen (x axis)
and the oxygen saturation (y axis). Many factors influence
the affinity of this binding, altering the curve shape. For
example, acidosis and body hyperthermia induce a right
shift of the curve. This shift promotes the release of
oxygen to the tissues.
Because high levels of ScvO2 could reflect an impaired
extraction of oxygen, our hypothesis was that ScvO2
levels above 80% in patients in septic shock hospitalized
in ICU should be correlated with an increased mortality
rate. The present study was aimed to correlate high
levels of ScvO2 with mortality.
Materials and methods
Approval by the Ethics Committee and informed con-
sent were waived due to the observational nature of the
study. From January 2008 to December 2009, the charts
* Correspondence: julien.textoris@gmail.com
Service d’anesthésie et de réanimation. Hôpital Nord, Assistance Publique -
Hôpitaux de Marseille, Université de la Méditerranée, Chemin des bourrely,
13915, Marseille Cedex 20, France
Textoris et al. Critical Care 2011, 15:R176
http://ccforum.com/content/15/4/R176
© 2011 Textoris et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.of all patients admitted to the ICU of our institution
(Hôpital Nord, Marseilles, France) were retrospectively
screened. We included patients aged ≥ 18 yrs in septic
s h o c k ,a sd e f i n e de l s e w h e r e[ 3 ] ,a n da tl e a s tt w oa v a i l -
able ScvO2 samples within the first 72 hours of shock.
The patients with an ICU stay < 24 hours were
excluded.
The central venous catheter sampling site was in the
superior vena cava. The position of the tip of the catheter
was checked with chest radiography. Within the first 72
hours of shock, we collected the maximal ScvO2 (ScvO2-
max), and minimal ScvO2 (ScvO2min) levels. The character-
istics of patients were also collected, including:
demographics (age, sex, body mass index (BMI), admission
simplified acute physiology score (SAPS) II [4], and
sequential organ failure assessment (SOFA) score (mea-
sured at the onset of shock)) [5]. Variables such as plasma
lactate level, plasma creatinine level, daily urine output,
ratio of arterial oxygen pressure related to inspired oxygen
fraction (PaO2/FiO2), hemoglobin, heart rate, mean arter-
ial pressure, pulsatile saturation in oxygen (SpO2)a n d
body temperature were recorded contemporary to the
ScvO2max value. The patients were stratified according to
their hospital mortality. The patients in septic shock were
managed according to our local protocol in agreement
with the Surviving Sepsis Campaign guidelines [1]. Briefly,
fluid resuscitation was conducted according to dynamic
indices of preload (pulse pressure variations and stroke
volume variations) and echocardiography data analysis.
Norepinephrine was used as the first line vasopressor in
order to achieve a mean arterial pressure of 65 mmHg. As
reported elsewhere, positive inotropes (dobutamine or iso-
proterenol) were introduced in the patients with low car-
diac index and ScvO2 < 70% [1,6]. Renal replacement
therapy was used only in patients exhibiting anuria or
elevated potassium levels.
Statistical calculations were performed using the R pro-
ject software (version 2.10). For continuous and ordinal
variables, data were expressed as median with interquartile
range. Comparisons between the two groups (survivors
and non-survivors) were performed for epidemiological
data and for hemodynamic data using a Mann-Whitney U
test. For dichotomous variables, percentages were com-
puted. Comparisons of percentages were performed with
the Chi² test. We also performed a multivariate analysis by
logistic regression to control for potential confounders in
evaluating the relationship between ScvO2max and out-
come. Variables introduced into the model were those
found to be significant in univariate analysis (with the
exception of creatinine level, known to be linked to daily
urine output, and SAPS II): body temperature, daily urine
output, ScvO2max, and plasma lactate. We checked the
prediction models’ residuals were distributed normally. All
comparisons were two-tailed, and P=0.05 was required
to exclude the null hypothesis.
Results
The screening of 1,976 charts identified 152 (7.7%)
patients in septic shock fulfilling the inclusion criteria
(Figure 1). All the patients received sedation (Ramsay
score between 3 and 5) and were ventilated. Norepi-
nephrine was used in all patients. Thirty-four (22%)
patients were treated by positive inotrope. Ninety-one
(60%) patients were discharged from the hospital. At
admission, the SAPS II score was significantly higher in
the non-survivors than in the survivors (58 (38 to 72)
vs. 44 (33 to 55); P=0.01). At the onset of septic shock,
the SOFA score did not differ between the survivors
and the non-survivors. The body temperature and the
daily urine output were higher in the survivors than in
the non-survivors (38.1°C (37.3 to 39) vs 37.2°C (36.5 to
38), P = 0.00004, and 1,200 mL/day (700 to 1,600) vs
685 mL/day (415 to 1,425), P = 0.006, respectively). The
plasma creatinine level and the plasma lactate level were
l o w e ri nt h es u r v i v o r st h a ni nt h en o n - s u r v i v o r s( 1 0 2
μmol/L (73 to 161) vs 186 μmol/L (98 to 280), P =
0.0002, and 2.1 mmol/L (1.5 to 2.9) vs 2.4 mmol/L (1.8
to 3.7), P=0.05, respectively) (Table 1).
The ScvO2max was 83% (74 to 88%) and the median
ScvO2min was 68% (62 to 73%). Minimal ScvO2 was not
different between the survivors and the non-survivors
(Table 1). In contrast, the ScvO2max was of 79% (72 to
87%) in the survivors, as compared with 85% (78 to 89%)
in the non-survivors (P = 0.009) (Figure 2). In these
patients, only a high level of ScvO2max (OR = 1.06; CI
95% = (1.01 to 1.13)) and a lower body temperature
(OR = 0.48; CI 95% = (0.32 to 0.70)) were associated with
hospital mortality. A contingency table with a cut-off of
ScvO2max at 80% is shown in Table 2. According to this
cut-off, the rates of mortality were 30% (ScvO2max < 80%)
and 48% (ScvO2max ≥ 80%), respectively (P = 0.04).
Discussion
In the present study, the ScvO2min cannot serve to dis-
criminate the survivors and the non-survivors, and high
ScvO2max levels are associated with increased mortality.
Thus, a dysoxia with an impaired extraction of oxygen
may be suspected in septic shock patients.
The ScvO2min was not associated with increased mor-
tality. At first glance, this finding can be surprising. In
the emergency department (ED), an early correction of
ScvO2 was related to improved outcome [7]. In the ICU,
the baseline values of SvO2 (69% [8]) seem to be higher
than that observed in the ED (49% [7]). Thus, although
an aggressive resuscitation of the subgroup of patients
with ScvO2 below 70% may be beneficial, these low levels
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Page 2 of 6are less frequently observed in ICU patients than in ED
patients. Low ScvO2 levels may be due to a combination
of enhanced oxygen consumption, inadequately low car-
diac index, low hemoglobin concentrations, and/or low
arterial oxygen content. In the present study, all patients
had endotracheal intubation and were ventilated. In addi-
tion, they were sedated by a combination of sufentanil
and midazolam. Probably both of these treatments mini-
mized the oxygen consumption [9]. In addition, the
mean SpO2 was 96%, and the mean level of hemoglobin
at 9.5 g/dL. Thus, in the majority of our patients, a low
level of ScvO2 may only reflect an inadequately low car-
diac index [10]. This particular case is infrequent in ade-
quately resuscitated septic shock patients [11].
One of the objectives of septic shock resuscitation is
to raise the ScvO2 level above 70%. Our study
underlines that in patients with organ failure, high
ScvO2 values may be a marker of unfavorable outcome.
This result may not be generalizable to all septic
patients. All our patients were sedated and mechanically
ventilated. A previous study showed that SvcO2
increases significantly in response to intubation [9]. In
addition, the ScvO2 values were obtained within the first
72 hours of ICU stay. This differs from a previous study,
which was performed after the patient admission in the
ED [7]. Future strategies should include subgroup strati-
fication based on the ScvO2 levels. Such a model was
suggested for patients admitted to the ED [12]. In this
study, ScvO2 levels were stratified into three groups:
hypoxia (ScvO2 < 70%); normoxia (ScvO2 71% to 89%);
and hyperoxia (ScvO2 90% to 100%). Using a multivari-
ate analysis, the authors showed that hyperoxia was
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Figure 1 Flowchart of the study.
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Page 3 of 6associated with increased mortality. Similar results were
reported after cardiac surgery [13].
This clinical finding supports the hypothesis of a
decreased use of oxygen in sepsis [14]. An acquired defect
in oxidative phosphorylation prevents cells from using
molecular oxygen for adenosine triphosphate production
and potentially causes sepsis-induced organ dysfunction.
This misuse of oxygen, so-called cytopathic dysoxia, can
result in high levels of ScvO2. In our study, we used an
arbitrary cut-off at 80%. The difference in mortality
between the patients with ScvO2max value below or above
80% may generate clues regarding specific therapeutic
strategies such as administering ubiquinone derivative
targeted towards mitochondria in septic patients with
dysoxia [15].
One may suspect microcirculatory impairments in
patients with high ScvO2 levels. In line with this hypoth-
esis, plasma lactate levels were higher in the non-survivors
than in the survivors. Nevertheless, we did not find that
ScvO2max levels and plasma lactate levels were correlated
(data not shown, assessed by a generalized linear model,
P = 0.62, r² = 0.14). The rise of plasma lactate level in
shock is not only due to tissue hypoxia, but it can also be
the consequence of the muscular aerobic Na
+/K
+ ATPase
driven production in response to an intense catecholami-
nergic stimulation [16]. This second mechanism may
explain the absence of correlation. The microcirculation
remains to be evaluated in septic patients with dysoxia. In
a prior study, we showed that low tissue oxygen saturation
(StO2) was associated with increased mortality [17]. It
would be interesting to investigate specifically the micro-
circulation of patients with high levels of ScvO2.
Table 1 Results of univariate analysis
All patients n = 152 Survivors n = 91 Non-survivors n =6 1 P
Sex female 51 (34) 31 (34) 20 (33) 0.99
Age (yrs) 65 (53 to 74) 66 (52 to 74) 64 (57 to 75) 0.29
Body mass index 24 (22 to 28) 24 (22 to 28) 24 (22 to 29) 0.77
Body temperature (°C) 38.0 (37.0 to 38.5) 38.1 (37.3 to 39.0) 37.2 (36.5 to 38.1) 0.00004*
ScvO2min (%) 68 (62 to 73) 69 (63 to 73) 68 (60 to 73) 0.61
ScvO2max (%) 83 (74 to 88) 79 (72 to 87) 85 (78 to 89) 0.009*
Heart rate (beats/minute) 105 (93 to 120) 104 (92 to 117) 108 (94 to 127) 0.21
Mean arterial pressure (mmHg) 71 (62 to 81) 74 (63 to 77) 68 (61 to 81) 0.07
SpO2 (%) 96 (93 to 100) 96 (94 to 100) 96 (92 to 98) 0.16
Glasgow Coma Scale 15 (12 to 15) 15 (13 to 15) 13 (7 to 15) 0.09
Urine output (mL/day) 1,100 (600 to 1,600) 1,200 (700 to 1,600) 685 (415 to 1,425) 0.006*
Creatinine (μmol/L) 119 (78 to 204) 102 (73 to 161) 186 (98 to 280) 0.0002*
PaO2/FiO2 280 (123 to 365) 321 (128 to 380) 184 (131 to 202) 0.16
Hemoglobin (g/dL) 9.5(8.5 to 11.0) 9.7 (8.5 to 10.9) 9.4 (8.4 to 10.6) 0.51
pH
Lactate (mmol/L)
7.35 (7.27 to 7.41)
2.1 (1.6 to 3.4)
7.37 (7.32 to 7.41)
2.1 (1.5 to 2.9)
7.33 (7.21 to 7.41)
2.4 (1.8 to 3.7)
0.11
0.05*
ICU stay (days) 8 (4 to 19) 8 (4 to 18) 8 (4 to 20) 0.93
SAPS 2 47 (37 to 63) 44 (33 to 55) 58 (38 to 72) 0.01
SOFA 7 (5 to 11) 7 (3 to 10) 8 (5 to 11) 0.40
ICU, intensive care unit; PaO2/FiO2 ratio, ratio of arterial oxygen pressure related to inspired oxygen fraction; SAPS, simplified acute physiologic score; SpO2, pulse
oxymetry; SvcO2, central venous oxygen saturation; SOFA, Sequential Organ Failure Assessment score.
*variable included in the multivariate analysis. Results are expressed as number (percentage) or median (Interquartile range), as required.
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Figure 2 Maximal central venous oxygen saturation (ScvO2max)
is higher in the non-survivors than in the survivors.
Table 2 Contingency table of mortality among a
ScvO2max cut-off of 80%
Non survivors Survivors Mortality (%) P-value
ScvO2max < 80% 20 46 30 0.04
≥ 80% 41 45 48
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Page 4 of 6The present study has several limitations. As this single-
center study is retrospective, a selection bias might be
possible. In our protocol, we did not measure ScvO2 con-
tinuously, thus we might have missed several events. We
did not measure oxygen consumption, which may be
important for the interpretation of this finding. Moreover,
as we collected ScvO2 during the first 72 hours of resusci-
tation, ScvO2 measurements may reflect various states of
the treatment. One can suggest that the arterial oxygen
saturation may influence the ScvO2 levels. However,
this variable did not differ between survivors and non-
survivors. Another selection bias might be that patients
with a low venous oxygen saturation are more likely to die
in the first 48 hours after the onset of septic shock. How-
ever, in our study, only nine patients (6%) died within this
period. Their mean ScvO2min levels were 68%. As we sta-
ted in the methods section, our protocol includes a pre-
load assessment to guide fluid and global hemodynamic
management of patients. At the bedside, the cardiac out-
put was continuously monitored in more than 60% of our
patients. Unfortunately, these data were not systematically
reported in our patients’ charts. More than 10% of data
was lacking, therefore rendering the analysis difficult. Nor-
epinephrine was used in all our patients to achieve a mean
arterial pressure of 65 mmHg. The restoration of hemody-
namics by using vasopressors may cause venous hyperoxia,
by increasing cardiac output. As the use of high doses of
vasopressors has been associated with increased mortality
[18], this may be another potential confounding factor.
Conclusions
In conclusion, high levels of ScvO2 in septic shock
patients may be associated with increased mortality.
Future studies relating outcome and ScvO2 should stra-
tify the patients according to venous hypoxia, normoxia
and hyperoxia levels.
Key messages
￿ High levels of ScvO2 (> 80%) during the first 72
hours of resuscitation of septic shock patients is asso-
ciated with increased mortality
￿ High levels of ScvO2 could reflect an impaired use
of oxygen
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